EMEA Presenting at the 74th session of the World Health Organisation Committee for Europe
EMEA News for October 2024
In 2023 the European ME Alliance received ‘
official Non-State Actor accreditation’ status
from WHO’s Regional Office for Europe during WHO Europe’s 73rd Regional Committee Meeting (RC73).
This status permits EMEA to participate in WHO Europe Regional Meetings and
to make official statements on agenda topics of interest.
EMEA aims to use this platform to improve awareness, recognition, and action for Myalgic Encephalomyelitis (ME) across
WHO Europe’s 53 member states.
EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item discussing the State of Health in the WHO European Region
The European ME Alliance made a statement at the #RC74CPH meeting on the agenda item discussing
the State of Health in the WHO European Region.
We called for a comprehensive and well-funded strategy
on ME because:
<0l>
We described key components of an ME/CFS strategy.
EMEA concluded with a firm appeal, stressing that the longstanding lack of governmental support has forced the national patient organisations and charities within the Alliance to fundraise and coordinate research independently.
"We cannot do this alone," EMEA stated, calling on WHO Europe and its member states for immediate support.
Further Reading:
- WHO Europe Message for International ME Conference Week Delegates
- EMEA Presenting at the 74th session of the World Health Organisation Committee for Europe
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item discussing the State of Health in the WHO European Region
- EMEA statement at 74th Regional Committee Meeting for Europe on the agenda item European regional action framework for behavioural and cultural insights for equitable health, 2022–2027